-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$9.00247.49% Upside
FibroBiologics, Inc. Common Stock Frequently Asked Questions
-
What analysts cover FibroBiologics, Inc. Common Stock?
FibroBiologics, Inc. Common Stock has been rated by research analysts at EF Hutton in the past 90 days.